The novel albumin-chitosan core-shell nanoparticles for gene delivery: Preparation, optimization and cell uptake investigation

Journal of Nanoparticle Research

Volumn 15, Issue 5, 2013, Pages

  Karimi, Mahdi ^a,b,c   Avci, Pinar ^b,c   Mobasseri, Rezvan ^a   Hamblin, Michael R ^b,c,d   Naderi Manesh, Hossein ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Albumin; Chitosan; Gene delivery; Nanoparticle; Optimization

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; CHITOSAN; CONTROLLED DRUG DELIVERY; CORE SHELL NANOPARTICLES; DNA; EFFICIENCY; GENE TRANSFER; GENES; NANOPARTICLES; OPTIMIZATION; PHASE SEPARATION; SHELLS (STRUCTURES); TARGETED DRUG DELIVERY;

ALBUMIN; BOX-BEHNKEN DESIGN; FLUORESCENT MICROSCOPY; GENE DELIVERY; INDEPENDENT VARIABLES; NANOPARTICLE SIZES; RESPONSE SURFACE METHODOLOGY; SEPARATION METHODS;

LOADING;

ALBUMIN; ALBUMIN CHITOSAN DNA CORE SHELL NANOPARTICLE; CHITOSAN; DNA; NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; RESPONSE SURFACE METHOD;

EID: 84876367226     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1651-0     Document Type: Article

References (52)

1. Arya G, Vandana M, Acharya S, Sahoo SK (2011) Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine: Nanotechnology, Biology and Medicine 7(6):859-870
2. Azarmi S, Tao X, Chen H, Wang Z, Finlay WH, Löbenberg R, Roa WH (2006) Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm 319(1-2):155-161
3. Banerjee N, Krupanidhi SB (2010) Facile hydrothermal synthesis and observation of bubbled growth mechanism in nano-ribbons aggregated microspherical Covellite blue-phosphor. Dalton Trans 39(41):9789-9793
4. Bansal KK, Kakde D, Gupta U, Jain NK (2010) Development and characterization of triazine based dendrimers for delivery of antitumor agent. J Nanosci Nanotechnol 10(12):8395-8404
5. Che H-L, Muthiah M, Ahn Y, Son S, Kim WJ, Seonwoo H, Chung JH, Cho C-S, Park I-K (2011) Biodegradable particulate delivery of vascular endothelial growth factor plasmid from polycaprolactone/polyethylenimine electrospun nanofibers for the treatment of myocardial infarction. J Nanosci Nanotechnol 11(8):7073-7077
6. Cryan SA, Holohan A, Donohue R, Darcy R, O'Driscoll CM (2004) Cell transfection with polycationic cyclodextrin vectors. Eur J Pharm Sci 21(5):625-633
7. De Laporte L, Cruz Rea J, Shea LD (2006) Design of modular non-viral gene therapy vectors. Biomaterials 27(7):947-954
8. De Souza Costa-Junior E, Pereira MM, Mansur HS (2009) Properties and biocompatibility of chitosan films modified by blending with PVA and chemically crosslinked. J Mater Sci Mater Med 20(2):553-561
9. Dong CH, Xie XQ, Wang XL, Zhan Y, Yao YJ (2009) Application of Box-Behnken design in optimisation for polysaccharides extraction from cultured mycelium of Cordyceps sinensis. Food Bioprod Process 87(2):139-144
10. Duan Y, Zheng J, Han S, Wu Y, Wang Y, Li D, Kong D, Yu Y (2008) A tumor targeted gene vector modified with G250 monoclonal antibody for gene therapy. J Control Release 127(2):173-179
11. El-Aneed A (2004) An overview of current delivery systems in cancer gene therapy. J Control Release 94(1):1-14
12. Elzoghby AO, Samy WM, Elgindy NA (2012) Albumin-based nanoparticles as potential controlled release drug delivery systems. J Controlled Release 157(2):168-182
13. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T (2003) In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24(7):1121-1131
14. Gazori T, Khoshayand MR, Azizi E, Yazdizade P, Nomani A, Haririan I (2009) Evaluation of Alginate/Chitosan nanoparticles as antisense delivery vector: formulation, optimization and in vitro characterization. Carbohydr Polym 77(3):599-606
15. Ge S, Kojio K, Takahara A, Kajiyama T (1998) Bovine serum albumin adsorption onto immobilized organotrichlorosilane surface: influence of the phase separation on protein adsorption patterns. J Biomater Sci Polym Ed 9(2):131-150
16. Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J (2006) RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 14(4):476-484
17. Huang P, Kong Y, Li Z, Gao F, Cui D (2010) Copper selenide nanosnakes: bovine serum albumin-assisted room temperature controllable synthesis and characterization. Nanoscale Res Lett 5(6):949-956
18. Irache JM, Merodio M, Arnedo A, Camapanero MA, Mirshahi M, Espuelas S (2005) Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs. Mini Rev Med Chem 5(3):293-305
19. Janes KA, Fresneau MP, Marazuela A, Fabra A, Alonso MJ (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 73(2-3):255-267
20. Kim TH, Jin H, Kim HW, Cho MH, Cho CS (2006) Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther 5(7):1723-1732
21. Kim J, Lee C-M, Jeong H-J, Lee K-Y (2011a) In vivo tumor accumulation of nanoparticles formed by ionic interaction of glycol chitosan and fatty acid ethyl ester. J Nanosci Nanotechnol 11(2):1160-1166
22. Kim T-H, Yu GS, Choi H, Shim YJ, Lee M, Choi JS (2011b) Preparation of dexamethasone-based cationic liposome and its application to gene delivery in vitro. J Nanosci Nanotechnol 11(2):1799-1802
23. Kommareddy S, Amiji M (2005) Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug Chem 16(6):1423-1432. doi: 10.1021/bc050146t
24. Kratz F (2008) Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 132(3):171-183
25. Kratz F, Fichtner I, Beyer U, Schumacher P, Roth T, Fiebig HH, Unger C (1997) Antitumour activity of acid labile transferrin and albumin doxorubicin conjugates in in vitro and in vivo human tumour xenograft models. Eur J Cancer 33(1008):175
26. Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D (2003) Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm 257(1-2):169-180
27. Lavertu M, Méthot S, Tran-Khanh N, Buschmann MD (2006) High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27(27):4815-4824
28. Lee D, Lockey R, Mohapatra S (2006) Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans. J Nanosci Nanotechnol 6(9-10):2860-2866
29. Lee K-M, Lee Y-B, Oh I-J (2011) Evaluation of PEG-transferrin-PEI nanocomplex as a gene delivery agent. J Nanosci Nanotechnol 11(8):7078-7081
30. Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, Beaumont E, Fernandes JC (2006) Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27(9):2060-2065
31. Mao H-Q, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Controlled Release 70(3):399-421
32. Mao S, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 62(1):12-27
33. Mayer G, Vogel V, Weyermann J, Lochmann D, van den Broek JA, Tziatzios C, Haase W, Wouters D, Schubert US, Zimmer A, Kreuter J, Schubert D (2005) Oligonucleotide-protamine-albumin nanoparticles: protamine sulfate causes drastic size reduction. J Control Release 106(1-2):181-187
34. Muthukumar M, Mohan D, Rajendran M (2003) Optimization of mix proportions of mineral aggregates using Box Behnken design of experiments. Cement Concr Compos 25(7):751-758
35. Nagpal K, Singh SK, Mishra DN (2010) Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 58(11):1423-1430
36. Nasti A, Zaki NM, de Leonardis P, Ungphaiboon S, Sansongsak P, Rimoli MG, Tirelli N (2009) Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res 26(8):1918-1930
37. Park TG, Jeong JH, Kim SW (2006) Current status of polymeric gene delivery systems. Adv Drug Deliv Rev 58(4):467-486
38. Patil GV (2003) Biopolymer albumin for diagnosis and in drug delivery. Drug Dev Res 58(3):219-247
39. Rahbari R, Sheahan T, Modes V, Collier P, Macfarlane C, Badge RM (2009) A novel L1 retrotransposon marker for HeLa cell line identification. Biotechniques 46(4):277-284
40. Ren L-L, Wu Y, Han D, Zhao L-D, Sun Q-M, Guo W-W, Sun J-H, Wu N, Li X-Q, Zhai S-Q, Han D-Y, Young W-Y, Yang S-M (2010) Math1 gene transfer based on the delivery system of quaternized chitosan/Na-carboxymethyl-cyclodextrin nanoparticles. J Nanosci Nanotechnol 10(11):7262-7265
41. Rubino OP, Kowalsky R, Swarbrick J (1993) Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of cross-linking, and drug release. Pharm Res 10(7):1059-1065
42. Shao D, Sun H, Yu M, Lian J, Sawyer S (2012) Enhanced ultraviolet emission from poly(vinyl alcohol) ZnO nanoparticles using a SiO2-Au core/shell structure. Nano Lett 12(11):5840-5844
43. Singh HD, Wang G, Uludag H, Unsworth LD (2010) Poly-l-lysine-coated albumin nanoparticles: stability, mechanism for increasing in vitro enzymatic resilience, and siRNA release characteristics. Acta Biomater 6(11):4277-4284
44. Soto-Cruz O, Saucedo-Castañeda G, Pablos-Hach JL, Gutiérrez-Rojas M, Favela-Torres E (1999) Effect of substrate composition on the mycelial growth of Pleurotus ostreatus. An analysis by mixture and response surface methodologies. Process Biochem 35(1-2):127-133
45. Utsuno K, Uludag H (2010) Thermodynamics of polyethylenimine-DNA binding and DNA condensation. Biophys J 99(1):201-207
46. Wang G, Siggers K, Zhang S, Jiang H, Xu Z, Zernicke RF, Matyas J, Uludag H (2008) Preparation of BMP-2 containing bovine serum albumin (BSA) nanoparticles stabilized by polymer coating. Pharm Res 25(12):2896-2909
47. Weber C, Coester C, Kreuter J, Langer K (2000a) Desolvation process and surface characterisation of protein nanoparticles. Int J Pharm 194(1):91-102
48. Weber C, Kreuter J, Langer K (2000b) Desolvation process and surface characteristics of HSA-nanoparticles. Int J Pharm 196(2):197-200
49. Xu J, Yang X, Wang H, Chen X, Luan C, Xu Z, Lu Z, Roy VAL, Zhang W, Lee C-S (2011) Arrays of ZnO/ZnxCd1-xSe nanocables: band gap engineering and photovoltaic applications. Nano Lett 11(10):4138-4143
50. Xu P, Li W, Zhou H, Pan F, Xing H, Liu H (2012) Investigations of the structural evolution of electrospun nanofibers using atomic force microscopy. RSC Advances 2(29):11104-11110
51. Zhang S, Wang G, Lin X, Chatzinikolaidou M, Jennissen HP, Laub M, Uludag H (2008) Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery. Biotechnol Prog 24(4):945-956
52. Zhang S, Kucharski C, Doschak MR, Sebald W, Uludag H (2010) Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery. Biomaterials 31(5):952-963